Delaying or temporarily suspending<unk>  is a medical treatment for children whose<unk>  started abnormally early (precocious<unk> .<unk> s are also commonly used for children with idiopathic short stature, for whom these drugs can be used to promote development of long bones and increase adult height. In adults, the same drugs are used to treat endometriosis and prostate cancer.<unk> s prevent the development of biological secondary sex characteristics. They slow the growth of sexual organs and production of hormones. Other effects include the suppression of male features of facial hair, deep voices, and Adam's apples, and the halting of female features of breast development and menstruation.<unk> s are sometimes prescribed to young transgender people, to temporarily halt the development of secondary sex characteristics.<unk> s allow patients more time to solidify their gender identity, without developing secondary sex characteristics. If a child later decides not to transition to another gender the medication can be stopped, allowing<unk>  to proceed. Little is known about the long-term side effects of hormone or<unk> s in children with gender dysphoria. Although<unk> s are known to be safe and physically reversible treatment if stopped in the short term, it's also not known whether hormone blockers affect the development of the factors like bone mineral density, brain development and fertility in transgender patients.<unk> s give transgender youth a smoother transition into their desired gender identity as an adult. While few studies have examined the effects of<unk> s for gender non-conforming or transgender adolescents, the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals, and an association has been found between<unk> s and decreased lifetime suicidality. A 2020 UK Department of Health and Social Care commissioned review found that the quality of evidence was of very low certainty for<unk>  outcomes regarding mental health, quality of life and impact on gender dysphoria. Adverse effects on bone mineralization and compromised fertility are potential risks of<unk> l suppression in gender dysphoric youth treated with GnRH agonists. Additionally, genital tissue in transgender women may not be optimal for potential vaginoplasty later in life due to underdevelopment of the penis. Research on the long term effects on brain development is limited.
Puberty blocker
Sex-hormonal agent
Anxiolytic
Antiandrogen
Thyroid blocker
Prolactin modulator
Mood stabilizer
Abortifacient